tiprankstipranks
Advertisement
Advertisement
Dr. Reddy’s Laboratories Earnings Call Shows Mixed Momentum
PremiumCompany AnnouncementsDr. Reddy’s Laboratories Earnings Call Shows Mixed Momentum
2d ago
Dr. Reddy’s Q1 FY2026 Interim Financials Cleared in Independent Review
Premium
Company Announcements
Dr. Reddy’s Q1 FY2026 Interim Financials Cleared in Independent Review
3d ago
Dr. Reddy’s Unveils Q1 FY2027 Results, Bolsters Biologics Leadership and U.S. Audit Oversight
Premium
Company Announcements
Dr. Reddy’s Unveils Q1 FY2027 Results, Bolsters Biologics Leadership and U.S. Audit Oversight
3d ago
Ex-Dividend Dates Nearing for These 10 Stocks – Week of July 20, 2026
PremiumMarket NewsEx-Dividend Dates Nearing for These 10 Stocks – Week of July 20, 2026
6d ago
Dr. Reddy’s to Announce Q1 FY27 Results and Host Earnings Call on July 22, 2026
Premium
Company Announcements
Dr. Reddy’s to Announce Q1 FY27 Results and Host Earnings Call on July 22, 2026
12d ago
Dr. Reddy’s Files Form 6-K and Publishes July 9 Investor Call Recording
Premium
Company Announcements
Dr. Reddy’s Files Form 6-K and Publishes July 9 Investor Call Recording
15d ago
Innoviva announces distribution, licensing agreement with Dr. Reddy’s
PremiumThe FlyInnoviva announces distribution, licensing agreement with Dr. Reddy’s
1M ago
Dr. Reddy’s launches first-to-market generic Bosutinib 400mg in U.S. oncology market
Premium
Company Announcements
Dr. Reddy’s launches first-to-market generic Bosutinib 400mg in U.S. oncology market
1M ago
Dr. Reddy’s announces first-to-market launch of Bosutinib Tablets 400mg
Premium
The Fly
Dr. Reddy’s announces first-to-market launch of Bosutinib Tablets 400mg
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100